Bleeding before ITI according to maximum inhibitor titer before ITI (excluding patients receiving BPA prophylaxis)
| Titer . | 6-39 BU . | 40-199 BU . | ≥200 BU . | P value (≥200 vs 6-39 BU) . |
|---|---|---|---|---|
| Patients | 24 | 21 | 52 | |
| ABR | 6.38 (4.05-10.06) | 5.63 (3.43-9.25) | 5.97 (4.42-8.05) | .811 |
| AJBR | 1.63 (0.95-2.81) | 2.26 (1.28-3.97) | 2.90 (2.11-3.98) | .074 |
| Titer . | 6-39 BU . | 40-199 BU . | ≥200 BU . | P value (≥200 vs 6-39 BU) . |
|---|---|---|---|---|
| Patients | 24 | 21 | 52 | |
| ABR | 6.38 (4.05-10.06) | 5.63 (3.43-9.25) | 5.97 (4.42-8.05) | .811 |
| AJBR | 1.63 (0.95-2.81) | 2.26 (1.28-3.97) | 2.90 (2.11-3.98) | .074 |